Patents by Inventor Mayssa Attar

Mayssa Attar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20230181497
    Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Application
    Filed: July 18, 2022
    Publication date: June 15, 2023
    Inventors: Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Ching-Ming Chang, Richard S. Graham, Devin F. Welty
  • CYCLOSPORIN COMPOSITIONS
    Publication number: 20220409693
    Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
    Type: Application
    Filed: May 12, 2022
    Publication date: December 29, 2022
    Inventors: Richard S. Graham, Walter L. Tien, Mayssa Attar, Rhett Schiffman, Aileen Morgan
  • NON-IRRITATING TESTOSTERONE EMULSIONS
    Publication number: 20220202829
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Application
    Filed: November 12, 2021
    Publication date: June 30, 2022
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING
    Publication number: 20210315805
    Abstract: The present invention is directed to an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose which promotes epithelial wound healing in a patients cornea.
    Type: Application
    Filed: February 19, 2021
    Publication date: October 14, 2021
    Inventors: David A. Hollander, Linda Villanueva, Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Ching-Ming Chang, Richard S. Graham, Devin F. Welty
  • SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2
    Publication number: 20210236590
    Abstract: Disclosed herein are methods of treating diseases of the eye by administering to the subconjunctival space a formulation comprising cyclosporin A form 2 and a hydrogel.
    Type: Application
    Filed: October 5, 2020
    Publication date: August 5, 2021
    Inventors: Wendy M. Blanda, Mayssa Attar
  • CYCLOSPORIN COMPOSITIONS
    Publication number: 20210169971
    Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
    Type: Application
    Filed: October 7, 2020
    Publication date: June 10, 2021
    Inventors: Richard S. Graham, Walter L. Tien, Mayssa Attar, Rhett (Last name not provided), Aileen Morgan
  • NON-IRRITATING TESTOSTERONE EMULSIONS
    Publication number: 20210113588
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Application
    Filed: August 27, 2020
    Publication date: April 22, 2021
    Inventors: John` T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • Non-irritating testosterone emulsions
    Patent number: 10780098
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: September 22, 2020
    Assignee: ALLERGAN, INC.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20200197336
    Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Application
    Filed: March 2, 2020
    Publication date: June 25, 2020
    Inventors: Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Ching-Ming Chang, Richard S. Graham, Devin F. Welty
  • NON-IRRITATING TESTOSTERONE EMULSIONS
    Publication number: 20180221388
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 9, 2018
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • Non-irritating testosterone emulsions
    Patent number: 9937188
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: April 10, 2018
    Assignee: Allergan, Inc.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • CYCLOSPORIN COMPOSITIONS
    Publication number: 20170143792
    Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
    Type: Application
    Filed: February 6, 2017
    Publication date: May 25, 2017
    Inventors: Richard S. Graham, Walter L. Tien, Mayssa Attar, Rhett M. Schiffman, Aileen Morgan
  • Cyclosporin compositions
    Patent number: 9561178
    Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: February 7, 2017
    Assignee: Allergan, Inc.
    Inventors: Richard S. Graham, Walter L. Tien, Mayssa Attar, Rhett Schiffman, Aileen Morgan
  • Antibiotic conjugates directly linked with steroid drugs
    Patent number: 9402912
    Abstract: The present invention describes novel single drug entities, formed by direct linkage of an antibiotic to a steroidal drug. Upon topical application to the eye, the conjugate would undergo enzymatic and/or hydrolytic cleavage to release the individual drugs. The antibiotic is coupled directly to the steroid drug.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: August 2, 2016
    Assignee: Allergan, Inc.
    Inventors: Santosh C. Sinha, Ken Chow, Liming Wang, Michael E. Garst, Mayssa Attar, Brandon D. Swift
  • Cyclosporine A steroid conjugates
    Patent number: 9402913
    Abstract: The present invention describes Cyclosporine A/steroid hybrid analogs. These single drug entities are formed by connecting a steroid with Cyclosporine A. Upon topical application to the eye, the conjugate hybrid would undergo enzymatic and/or hydrolytic cleavage to release the individual drugs.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: August 2, 2016
    Assignee: Allergan, Inc.
    Inventors: Santosh C. Sinha, Ken Chow, Liming Wang, Michael E. Garst, Mayssa Attar, Brandon D. Swift
  • Ketorolac tromethamine compositions for treating or preventing ocular pain
    Patent number: 9192571
    Abstract: The present invention provides an aqueous ophthalmic solution with an effective amount of ketorolac and carboxymethyl cellulose in an aqueous solution which provides increased visual acuity and wherein the concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: November 24, 2015
    Assignee: Allergan, Inc.
    Inventors: Eldon Q. Farnes, Mayssa Attar, Rhett M. Schiffman, Chin-Ming Chang, Richard S. Graham, Devin F. Welty
  • CYCLOSPORIN EMULSIONS
    Publication number: 20150045309
    Abstract: Disclosed herein is a composition comprising cyclosporin A at a concentration between about 0.001% (w/v) and about 1.0% (w/v), a plant oil at a concentration between about 0.01% (w/v) and about 10% (w/v), and macrogol 15 hydroxystearate at a concentration between about 0.01% (w/v) and about 10% (w/v).
    Type: Application
    Filed: October 27, 2014
    Publication date: February 12, 2015
    Inventors: Aileen Morgan, Anuradha V. Gore, Mayssa Attar
  • NON-IRRITATING TESTOSTERONE EMULSIONS
    Publication number: 20140315872
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Application
    Filed: March 17, 2014
    Publication date: October 23, 2014
    Applicant: Allergan, Inc.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2
    Publication number: 20140296158
    Abstract: Disclosed herein are methods of treating diseases of the eye by administering to the subconjunctival space a formulation comprising cyclosporin A form 2 and a hydrogel.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 2, 2014
    Inventors: Wendy M. Blanda, Mayssa Attar
  • ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    Publication number: 20140256666
    Abstract: The present invention describes single drug entities, formed by connecting an antibiotic moiety via a linker with a non-steroidal anti-inflammatory drug (NSAID) moiety. Upon topical application to the eye, the conjugate hybrid would undergo enzymatic and/or hydrolytic cleavage to release the individual antibiotic and NSAID drug.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 11, 2014
    Applicant: Allergan, Inc.
    Inventors: Santosh C. Sinha, Smita S. Bhat, Ken Chow, LIMING WANG, MICHAEL E. GARST, MAYSSA ATTAR, BRANDON D. SWIFT